A Single Dose Study to Assess the Mass Balance Recovery, Absorption, Metabolism and Excretion of [14C]-NT-814 in Healthy Male Subjects After Oral Dosing
Latest Information Update: 02 Nov 2021
At a glance
- Drugs Elinzanetant (Primary)
- Indications Sex hormone disorders; Sleep disorders; Vasomotor symptoms
- Focus Pharmacokinetics
- Sponsors NeRRe Therapeutics
- 09 Dec 2020 New trial record